CNS Pharmaceuticals Soars After $22.5M Private Placement Announcement
Shares of CNS Pharmaceuticals climbed sharply after the company announced a private placement expected to generate about $22.5 million in gross proceeds. The transaction, involving common stock and pre-funded warrants purchased by institutional healthcare investors, is intended to fund an acquisition-driven strategy and support general corporate ne…